Dr. Timothy E. Vanduzer, MD

Dr. Vanduzer practices at Crownpoint Health Care Facility in Crownpoint, New Mexico, part of U.S. Department of Health and Human Services.

Dr. Vanduzer's NPI, 1023051760, was assigned on June 13, 2006. Dr. Vanduzer graduated from State University of New York at Buffalo School of Medicine in 1995. Dr. Vanduzer holds Nevada license 8687.

Dr. Vanduzer's primary practice is Crownpoint Health Care Facility, at Junction of Hwy 371, Crownpoint, NM 87313 in Mckinley County. The practice phone is (505) 786-5291. Dr. Vanduzer also practices at Crownpoint Health Care Facility, 343 E Rt 9, Crownpoint, NM 87313.

Dr. Vanduzer's primary practice is Crownpoint Health Care Facility in Crownpoint, New Mexico, part of U.S. Department of Health and Human Services. The medical group on file is Crownpoint Health Care Facility. Dr. Vanduzer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vanduzer practices. Vendor and product names are available with a free account.

Emergency medical services is Dr. Vanduzer's primary specialty in the NPI Registry, under taxonomy code 207PE0004X. Dmand AI has Dr. Vanduzer's licenses on file in 3 states: Nevada, New York and Utah.

CMS data shows 121 Medicare services from Dr. Vanduzer across 3 procedure codes in 2024, for 103 Medicare patients. Medicare paid $5,616 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Dr. Vanduzer in 2024. The largest group is 65 to 74, with 44 patients. 66% of them have high blood pressure, and 50% have diabetes. 61% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vanduzer's median patient age at 72, with 62% women.

In 2024, Dr. Vanduzer wrote 275 Medicare Part D claims for 121 patients. 86% of them were for generic drugs. CMS names the drug for 126 of them, across 6 drugs with 11 or more claims each, at $1,081 in total drug cost. In 2023, CMS named 176 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Vanduzer for performance year 2024, reported as part of a group.

CMS Open Payments shows 3 general payments to Dr. Vanduzer from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $28.

Dr. Vanduzer graduated from State University of New York at Buffalo School of Medicine in 1995.